Looking forward to seeing the nsclc late breaker data. My focus is on 1-49% pd1 category and looking to see increase in PFS and maybe slight improvement in ORR. 1-49% pd1 patients is the bulk of nsclc so very commercially relevant. Efti definitely the best performing io/io combo in this setting - but will the benefit be marginally significant to get big pharma onboard for a ph3 or will they be left to run it solo?
also good to see slide on insight-004 combo with merck germany reappear in latest presentation. i thought insigh-004 showed a promising enough signal to eventuate to a new trial but perhaps merck germany not interested.
- Forums
- ASX - By Stock
- IMM
- Overnight Market report
Overnight Market report, page-1131
-
- There are more pages in this discussion • 1,656 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMM (ASX) to my watchlist
|
|||||
Last
29.5¢ |
Change
0.005(1.72%) |
Mkt cap ! $428.5M |
Open | High | Low | Value | Volume |
29.0¢ | 29.8¢ | 29.0¢ | $539.5K | 1.834M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
15 | 214062 | 29.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
29.5¢ | 469318 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
15 | 214062 | 0.290 |
19 | 266746 | 0.285 |
19 | 557602 | 0.280 |
6 | 224918 | 0.275 |
9 | 226781 | 0.270 |
Price($) | Vol. | No. |
---|---|---|
0.295 | 469318 | 5 |
0.300 | 654947 | 7 |
0.305 | 155034 | 7 |
0.310 | 502791 | 5 |
0.315 | 142694 | 7 |
Last trade - 16.10pm 11/07/2024 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |